173 related articles for article (PubMed ID: 26631616)
1. The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer.
Zhao SG; Evans JR; Kothari V; Sun G; Larm A; Mondine V; Schaeffer EM; Ross AE; Klein EA; Den RB; Dicker AP; Karnes RJ; Erho N; Nguyen PL; Davicioni E; Feng FY
Clin Cancer Res; 2016 Apr; 22(7):1777-86. PubMed ID: 26631616
[TBL] [Abstract][Full Text] [Related]
2. Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.
Zhao S; Geybels MS; Leonardson A; Rubicz R; Kolb S; Yan Q; Klotzle B; Bibikova M; Hurtado-Coll A; Troyer D; Lance R; Lin DW; Wright JL; Ostrander EA; Fan JB; Feng Z; Stanford JL
Clin Cancer Res; 2017 Jan; 23(1):311-319. PubMed ID: 27358489
[TBL] [Abstract][Full Text] [Related]
3. Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.
Rajan P; Stockley J; Sudbery IM; Fleming JT; Hedley A; Kalna G; Sims D; Ponting CP; Heger A; Robson CN; McMenemin RM; Pedley ID; Leung HY
BMC Cancer; 2014 Dec; 14():977. PubMed ID: 25519703
[TBL] [Abstract][Full Text] [Related]
4. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.
Ross-Adams H; Lamb AD; Dunning MJ; Halim S; Lindberg J; Massie CM; Egevad LA; Russell R; Ramos-Montoya A; Vowler SL; Sharma NL; Kay J; Whitaker H; Clark J; Hurst R; Gnanapragasam VJ; Shah NC; Warren AY; Cooper CS; Lynch AG; Stark R; Mills IG; Grönberg H; Neal DE;
EBioMedicine; 2015 Sep; 2(9):1133-44. PubMed ID: 26501111
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.
Yang L; Roberts D; Takhar M; Erho N; Bibby BAS; Thiruthaneeswaran N; Bhandari V; Cheng WC; Haider S; McCorry AMB; McArt D; Jain S; Alshalalfa M; Ross A; Schaffer E; Den RB; Jeffrey Karnes R; Klein E; Hoskin PJ; Freedland SJ; Lamb AD; Neal DE; Buffa FM; Bristow RG; Boutros PC; Davicioni E; Choudhury A; West CML
EBioMedicine; 2018 May; 31():182-189. PubMed ID: 29729848
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.
Mangiola S; McCoy P; Modrak M; Souza-Fonseca-Guimaraes F; Blashki D; Stuchbery R; Keam SP; Kerger M; Chow K; Nasa C; Le Page M; Lister N; Monard S; Peters J; Dundee P; Williams SG; Costello AJ; Neeson PJ; Pal B; Huntington ND; Corcoran NM; Papenfuss AT; Hovens CM
BMC Cancer; 2021 Jul; 21(1):846. PubMed ID: 34294073
[TBL] [Abstract][Full Text] [Related]
7. Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.
Lin D; Ettinger SL; Qu S; Xue H; Nabavi N; Choi SYC; Bell RH; Mo F; Haegert AM; Gout PW; Fleshner N; Gleave ME; Pollak M; Collins CC; Wang Y
Oncotarget; 2017 Apr; 8(16):25928-25941. PubMed ID: 28460430
[TBL] [Abstract][Full Text] [Related]
8. Are short telomeres predictive of advanced cancer?
Shay JW
Cancer Discov; 2013 Oct; 3(10):1096-8. PubMed ID: 24124228
[TBL] [Abstract][Full Text] [Related]
9. Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression.
Zhao H; Logothetis CJ; Gorlov IP; Zeng J; Dai J
Comput Math Methods Med; 2013; 2013():917502. PubMed ID: 24367394
[TBL] [Abstract][Full Text] [Related]
10. Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy.
Björk JK; Ahonen I; Mirtti T; Erickson A; Rannikko A; Bützow A; Nordling S; Lundin J; Lundin M; Sistonen L; Nees M; Åkerfelt M
Oncotarget; 2018 Jul; 9(58):31200-31213. PubMed ID: 30131848
[TBL] [Abstract][Full Text] [Related]
11. High Dimensional Variable Selection with Error Control.
Kim S; Halabi S
Biomed Res Int; 2016; 2016():8209453. PubMed ID: 27597974
[TBL] [Abstract][Full Text] [Related]
12. Is grading of the index (dominant) nodule in prostate cancer of greater prognostic significance than global grading?
Samaratunga H; Egevad L; Delahunt B
Pathology; 2024 Feb; 56(1):141-142. PubMed ID: 37806944
[No Abstract] [Full Text] [Related]
13. TEX19 could function as a prognostic biomarker for prostate cancer.
Xiao Y; Wang J; Feng D; Zhang C
Asian J Surg; 2023 Dec; 46(12):5671-5673. PubMed ID: 37648546
[No Abstract] [Full Text] [Related]
14. KRT72 might serves as a prognostic biomarker for patients with prostate cancer.
Wang J; Xiao Y; Yu Q; Zhang C
Asian J Surg; 2023 Nov; 46(11):5382-5384. PubMed ID: 37673738
[No Abstract] [Full Text] [Related]
15. ZMYND10 could serve as a prognostic biomarker for patients with prostate cancer.
Wang J; Xiao Y; Li D; Zhang C
Asian J Surg; 2023 Nov; 46(11):5376-5378. PubMed ID: 37673741
[No Abstract] [Full Text] [Related]
16. PRR7 could serve as a prognostic biomarker for prostate cancer patients.
Guo Y; Yu Q; Ke M; Wang J
Asian J Surg; 2023 Nov; 46(11):5133-5135. PubMed ID: 37422382
[No Abstract] [Full Text] [Related]
17. Outlier.
Sharma V
Int J Epidemiol; 2021 Oct; ():. PubMed ID: 34597355
[No Abstract] [Full Text] [Related]
18. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNAs in prostate cancer: overview and clinical implications.
Malik B; Feng FY
Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.
Zhao SG; Chang SL; Spratt DE; Erho N; Yu M; Ashab HA; Alshalalfa M; Speers C; Tomlins SA; Davicioni E; Dicker AP; Carroll PR; Cooperberg MR; Freedland SJ; Karnes RJ; Ross AE; Schaeffer EM; Den RB; Nguyen PL; Feng FY
Lancet Oncol; 2016 Nov; 17(11):1612-1620. PubMed ID: 27743920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
